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General practice
Effect of asthma and its treatment on growth: four year
follow up of cohort of children from general practices in
Tayside, Scotland
C McCowan, R G Neville, G E Thomas, I K Crombie, R A Clark, I W Ricketts, A Y Cairns,
F C Warner, S A Greene, E White
Abstract
Objective: To investigate whether asthma or its
treatment impairs children’s growth, after allowing for
socioeconomic group.
Design: 4 year follow up of a cohort of children aged
1›15.
Setting: 12 general practices in the Tayside region of
Scotland.
Subjects: 3347 children with asthma or features
suggestive of asthma registered with the general
practices.
Main outcome measures: Height and weight
standard deviation scores.
Results: Children who lived in areas of social
deprivation (assessed by postcode) had lower height
and weight than their contemporaries (mean standard
deviation score − 0.26 (SD 1.02) and − 0.18 (1.15)
respectively, P < 0.001 for both). Children who were
receiving >400 ìg daily of inhaled steroids and who
were attending both hospital and general practice for
asthma care had lower height and weight than
average, independent of the effect of deprivation
(mean standard deviation score − 0.62 (1.01),
P = 0.002, for height and − 0.58 (0.94), P = 0.005, for
weight). Children receiving high doses of inhaled
corticosteroids also showed lower growth rates (mean
change in standard deviation score − 0.19 (0.51),
P = 0.003). However, no other children with asthma
showed growth impairment.
Conclusion: Most children with asthma were of
normal height and weight and had normal growth
rates. However, children receiving high doses of
inhaled steroids and requiring both general practice
and hospital services had a significant reduction in
their stature. This effect was independent from but
smaller than the effect of socioeconomic group on
stature.
Introduction
Some studies have shown that children with asthma
have impaired growth,1–4 some have shown this change
to be merely a transient phase brought on by a delay in
the onset of puberty,5 6 and others have found no
relation.7–9 The concerns of parents and health profes›
sionals about the safety of asthma treatment are
difficult to allay without modern large studies on the
topic.
The use of potent inhaled corticosteroids to
control asthma has led to speculation about the
specific effect they have on growth, with opinion once
again divided. Littlewood et al,1 among others,3 4 have
reported that children receiving high doses of inhaled
corticosteroids are shorter than average. Wolthers and
Pedersen found no effect on growth of low doses of
inhaled corticosteroids in children attending their
asthma clinic who were followed up over 4 years.4
The measurement of growth in children has itself
been an area of intense study, with new growth
references for the United Kingdom being produced
and new methods for measuring growth being
championed.10–12 The Tanner growth standards devel›
oped in the 1960s and commonly used throughout the
United Kingdom13 were shown to be out of date as the
average height of British children had increased over
time.14 15 The method of comparing the growth in chil›
dren also changed, with a standard deviation score
being preferred to the growth centile. New methods of
calculating growth have led to the development of new
growth charts.12
Several growth studies in general populations have
investigated the effect of socioeconomic group on
growth and have shown that children from more
socially deprived backgrounds tend to be shorter.16–18
Results from the Tayside growth study support this and
also suggest that children from Tayside are in general
shorter than the average height for children in the
United Kingdom. Studies examining links between
socioeconomic group and asthma have been evenly
divided about an effect.19
Previous studies on growth and asthma have been
hospital based, looking at children with severe asthma
referred from the local community. Many of these did
not allow for socioeconomic influences on growth or
use modern population based methods for comparing
growth.
The cohort of children in the Tayside childhood
asthma project had asthma of varying severity and was
drawn from primary care in one region. Previous work
in this cohort found that children receiving high doses
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of inhaled steroids were shorter than expected.20 The
opportunity thus arose to study height and weight over
time and so investigate the relation between growth,
asthma, its treatment, and other factors such as
deprivation and use of health services.
Subjects and methods
Subjects
Two independent long term studies formed the basis
for this study. The Tayside growth study accurately
measured the height and weight of children in the
region every two years from 1989 to 1995, while the
Tayside childhood asthma project independently
tracked the management of an identified group of chil›
dren with asthma or features suggestive of asthma
from 1990 to 1995.21 22
The children in the Tayside childhood asthma
project were traced through the growth study and their
growth records combined with their medical records to
form a single database. Some growth measurements
retrieved were outside the scope of the childhood
asthma project because the growth study ran for
slightly longer than the asthma project, the asthma
project had a broader age band, and some children
changed general practice during the course of the
studies. When children changed general practice they
would no longer participate in the child asthma project
but could still be measured in the growth study.
Heights and weights of individual children were
converted to standard deviation scores for boys and girls
separately using the LMS method.12 The reference
population used to calculate the scores was all Tayside
children ( > 20 000) in the year the measurement was
obtained.18 When a child had two or more height meas›
urements separated by at least six months the change in
height standard deviation score between consecutive
measurements was used to monitor growth rate.23
Each child’s asthma treatment was classed accord›
ing to the British Thoracic Society’s treatment steps
0›4.24 The highest treatment step was used for children
who were prescribed different treatments within the
same year.
Each child was also grouped according to his or her
annual use of health services to give an indicator of the
severity of asthma. The children were grouped into
three categories: those who had received no attention
for asthma, those who received attention solely from
their general practice, and those who received
attention at both hospital and their general practice.
Home postcodes for all children were recorded, and
these were used to assign an index of deprivation based
on the 1991 census.25 The children were then grouped
into quarters according to the value of their index of
deprivation. This gave a group of high socioeconomic
status, two moderate groups, and one group with low
socioeconomic status, which contained children who
were socially deprived. The index of deprivation used
was determined according to the prevalence of several
different factors within each postcode: unemployment,
overcrowding, lack of amenities, children in unsuitable
accommodation or in low earner households, no car,
and single parent families. The index had a range of val›
ues in which the national average was zero, better than
average scores were negative, and worse than average
scores were positive.
Statistical methods
The main measurements analysed were height and
weight standard deviation score. Mean scores in
subgroups defined by treatment step and use of health
services were compared with the reference population
of the Tayside growth study21 and with each other. Vari›
ous statistical methods were used to interpret
differences between group mean scores.
In a large population the distribution of standard
deviation scores is normal and so any subgroup drawn
at random from the population should also have a
mean score of 0 with a standard deviation equal to 1,
apart from variation due to sampling. If the mean of a
sample of size n is outside the limits of –2/n there is
evidence of a difference from the reference population.
Again, in a large population change in height standard
deviation scores between two given ages should be
normally distributed, with a mean of 0 and a standard
deviation equal to (2(1-r)), where r is the correlation
between standard deviation scores at the two ages.23 An
average value for r over the age range in the study was
between 0.85 and 0.9, giving a standard deviation for
mean change in height standard deviation score of
between 0.55 and 0.45.
For all variables the one way analysis of variance
was used to compare subgroups of children. After the
effects of confounding covariates were allowed for,
pairwise subgroups of interest were compared using
Scheffe’s post hoc test. For two subgroups this
approach is equivalent to Student’s t test. When the
grouping of children was ordered, a possible trend
across the groups was investigated using a simple
linear trend term with its associated F test.
Ethics
The project was approved by the Tayside Medical Eth›
ics Committee, and all computer data were stored
under the terms of the Data Protection Act.
Results
The cohort
A cohort of 3437 children were identified from their
medical records as having asthma or asthma related
features.22 26 Twenty six children were removed from
the study because they had systemic diseases that could
impair their growth—for example, cystic fibrosis,
congenital heart disease, or Down’s syndrome. Height
measurements were traced for 2853 (84%) of the
remaining children. The 558 children without a trace›
able measurement showed a similar breakdown by
treatment step and use of health services to that in the
children who had a measurement, but the proportion
of girls was higher (table 1). In addition, 498 children
who had no related asthma record for the year a
growth measurement was taken were discounted from
any further analysis.
This left 2355 children (69% of the population of
the Tayside childhood asthma project) who had at least
one height measurement recorded in a year when their
asthma treatment was documented. There was a slight
preponderance of boys (1355/2355 (58%)), and the
average age of children at the time of the last growth
measurement was 9.7 years. The distribution of stand›
ard deviation scores for the height and weight of this
cohort showed no obvious differences from the
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normal distribution for the Tayside population.21 In all,
1405 children had height measurements taken on two
or more occasions at least six months apart (table 2).
Deprivation
Table 2 shows the means and standard deviations for
height and weight standard deviation scores when the
children were grouped by the index of deprivation.
The affluent groups were taller and heavier on average
than the reference population, while the most deprived
children were shorter and lighter on average. Overall,
children were on average shorter and lighter with
increasing deprivation. There was very strong evidence
of differences between the deprivation groups for both
height and weight standard deviation score (P < 0.001
for both). For both variables most of the variation
could be accounted for by a simple linear trend with
degree of deprivation.
Treatment step
When the children were classed by treatment steps,24
only the group of children receiving step 4 treatment
(high doses of inhaled steroids) was found to be
shorter on average than the reference population,
although there was no strong evidence that the group
was lighter on average (table 2).
When the effect of deprivation on height standard
deviation score was allowed for, the children at
treatment step 4 were significantly shorter than the
others (P = 0.02). For weight there were no differences
between treatment groups (P = 0.2). However, mean
weight standard deviation score declined with treat›
ment step by 0.047 (SE 0.019) per step (P = 0.02).
Use of health services
The children who had received medical care from both
their general practitioner and hospital services were
shorter and lighter on average than expected, whereas
the other two groups showed no differences from the
reference population (table 2).21
For height there was no evidence of differences
between the three groups after allowing for the effects
of deprivation (P = 0.16), but for weight there was
evidence of differences (P = 0.002), the group receiving
care from both their general practice and hospital
being lighter on average than the other groups.
The children were classed by treatment step (step 4
v the rest) and use of health services (general
practitioner and hospital v the rest) (table 3). The chil›
dren receiving step 4 treatment and care from both
hospital and general practitioner were shorter and
lighter than expected. Even after allowance was made
for degree of deprivation, these children were on aver›
age shorter (P = 0.002) and lighter (P = 0.003) than the
other children. On average, height and weight of
children in the three other groups showed no
differences from the reference population or from
each other.
Growth rates
There were no differences in growth rates for any of
the deprivation groups when compared with the
expected average growth rate of the reference popula›
tion (table 2). There was also no evidence of a trend
throughout these four groups as deprivation increased
(P = 0.13).
Table 1 Characteristics of children with and without growth
measurement. Values are numbers (percentages) of children
Without growth
measurement
(n=558)
With growth
measurement
(n=2853)
Sex:
Male 290 (52) 1648 (58)
Female 268 (48) 1205 (42)
BTS treatment step24:
0 362 (65) 1924 (67)
1 101 (18) 435 (15)
2 10 (2) 61 (2)
3 36 (6) 174 (6)
4 49 (9) 259 (9)
Use of health services:
No contact 304 (54) 1594 (56)
GP only 227 (41) 1124 (39)
GP and hospital services 27 (5) 135 (5)
BTS=British Thoracic Society; GP=general practitioner.
Table 2 Height and weight distribution of children with growth record and associated asthma record
Population
Height Weight Change in height SDS
No of
children Mean (SD)
No of
children Mean (SD)
No of
children Mean (SD)
All 2355 −0.02 (1.02) 2135 0.03 (1.07) 1405 0.00 (0.54)
Social status:
Very affluent 545 0.16 (1.01)* 480 0.15 (0.99)* 333 0.02 (0.55)
Affluent 546 0.09 (0.99)* 463 0.16 (1.15)* 324 0.04 (0.50)
Deprived 554 −0.07 (1.01) 517 0.02 (0.98) 363 −0.02 (0.53)
Very deprived 552 −0.26 (1.02)* 520 −0.18 (1.15)* 385 −0.02 (0.57)
Unknown 158 −0.06 (1.04) 155 0.03 (1.06)
BTS treatment step24:
0 1405 −0.01 (1.03) 1287 0.05 (1.09) 894 0.01 (0.56)
1 573 0.02 (1.00) 508 0.06 (1.00) 284 0.03 (0.50)
2 82 0.00 (1.00) 65 −0.03 (1.09) 38 0.11 (0.49)
3 126 −0.02 (1.00) 121 −0.15 (1.02) 80 −0.00 (0.47)
4 169 −0.28 (1.05)* 154 −0.12 (1.22) 109 −0.19 (0.51)*
Use of health services:
No contact 1065 −0.03 (1.03) 979 0.04 (1.11) 691 0.01 (0.58)
GP only 1171 0.01 (1.00) 1047 0.05 (1.04) 654 0.00 (0.50)
GP and hospital services 119 −0.32 (1.13)* 109 −0.32 (1.02)* 60 −0.07 (0.49)
SDS=standard deviation score; BTS=British Thoracic Society; GP=general practitioner.
*Significantly different from reference population of Tayside growth study.21
General practice
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When classed by treatment step, only the children
on step 4 showed a lower growth rate than the
reference population (table 2).21 Also, this group had a
significantly lower growth rate than the others
(P = 0.003).
The average growth rates of the children classed by
use of health services showed no differences from the
reference population or between the three groups
(P = 0.27). A comparison of children given step 4
treatment who were attending hospital and their general
practitioner for asthma management with those on step
4 who were not showed no differences between the two
groups, although the growth rate was lower in both
groups than for the reference population (table 3).21
Discussion
The results from this study show that most children
being treated for asthma do not have growth
impairment. A small subset of children were signifi›
cantly shorter and lighter, and this was principally
associated with low socioeconomic group but with
some association with asthma.
Children in this study receiving step 4 treatment in
the British Thoracic Society’s guidelines (high doses of
inhaled corticosteroids)24 who use hospital services are
shorter and lighter than expected and also have
comparatively poor growth rates. Those on step 4 who
did not use hospital services were of normal height and
weight but also showed comparatively poor growth
rates. The reduction in stature due to asthma is not
simply a result of treatment but arises from a complex
interplay of factors, possibly including degree of
control and the underlying severity of asthma. At
present we are unable to quantify any such effects.
Socially deprived children as determined by
postcode were significantly shorter and lighter than the
reference population. The children from more affluent
backgrounds were significantly taller and heavier than
the reference population. These results agree with
those reported by other growth studies.16–18 By contrast
there were no differences in average growth rates
across the socioeconomic scale.
Severity of asthma, whether classed by treatment or
use of health care facilities, was not strongly associated
with socioeconomic group. There was a trend for chil›
dren with severe asthma, by intensity of treatment or
care, to be poorer, but it was not significant.
Problems with methods
There are many difficulties with large scale population
studies such as this. The Tayside growth study was
designed to monitor the change in growth of the
population, not individual children, and so pubertal
stage was not recorded when measurements were
taken. Thus the study is not able to determine whether
asthma or its treatment have an effect on puberty or
indicate what effect might be present. As asthma was
generally assessed only once for each child, we could
not assess the effects on growth of the duration of
asthma or its treatment.
Data collection in the Tayside childhood asthma
project was restricted to general purpose general
practitioner medical records, so it was difficult to obtain
an objective assessment of the severity of asthma that
was independent of the treatment. As a compromise,
children were classed by use of health services, which
was considered to be a proxy for the impact of asthma
on children.
Using a large, current, and local population allows
easy comparison of different growth measurements by
standard deviation score. The method devised by Cole
and Green allows the standard deviation score of chil›
dren of different age and sex to be compared, so popu›
lations of children can be studied.12 The population was
drawn from 12 different Tayside general practices, so
gave it a representative sample of the region. The 12
general practices had been selected to give a mix of
urban and rural areas, single handed and multipartner
practices, and practices with and without an asthma
clinic.22 Any strong socioeconomic bias from drawing
subjects from a single centre was avoided, and the
group included the full range of asthma, which is not
found in specialist hospital asthma clinics.
Deprivation
An index of deprivation based on postcode allows the
effect of socioeconomic group on asthma and growth
to be assessed. That our marker was based on a
validated index of deprivation,25 only the single parent
family factor being different, should allay fears that a
biased marker was used. The findings confirm that
growth is related to socioeconomic group.16–18 The sug›
gestion of a trend for people from poorer
socioeconomic groups to have more severe asthma
agrees with some recent publications, although
previous work is divided about the effect of social
group on asthma.19 We could not obtain specific data
on deprivation for the Tayside population as the home
postcodes for individual children were not recorded.
Within the confines of this study we were not able to
determine whether the prevalence of asthma was
affected by the degree of deprivation.
Table 3 Height and weight in children classed by British Thoracic Society treatment step24 and use of hospital services
Population
Height Weight Change in height SDS
No of
children Mean (SD)
No of
children Mean (SD)
No of
children Mean (SD)
Treatment steps 0›3
Use of health services:
No contact and GP only 2130 −0.01 (1.01) 1932 0.04 (1.06) 1276 0.02 (0.54)
GP and hospital 56 0.02 (1.18) 49 −0.01 (1.04) 20 0.16 (0.47)
Treatment step 4
Use of health services:
No contact and GP only 106 −0.07 (1.03) 94 0.17 (1.29) 69 −0.19 (0.54)*
GP and hospital 63 −0.62 (1.01)* 60 −0.58 (0.94)* 40 −0.18 (0.46)*
SDS=standard deviation score; GP=general practitioner.
*Significantly different from reference population of Tayside growth study.21
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Conclusion
Our findings could help explain why there has been
such a diversity in the results from previous work.27
Community based studies have shown that asthma has
no effect on growth, while hospital studies concentrat›
ing on small numbers of severely asthmatic children
receiving high doses of inhaled steroids have reported
impaired growth. Our study suggests that only a small
subset of children have impaired stature—those who
require hospital management and are prescribed high
doses of inhaled steroids—and this would explain the
findings of previous reports. If these children are
included as part of a larger community based study the
impairment to their stature is masked by children
whose stature is not affected. The results also imply that
high doses of inhaled corticosteroids may affect growth
rate. Whereas the paper cannot answer the debate on
severity and treatment, high doses of inhaled steroids
seem not to affect stature, although they may adversely
effect growth rate. Reduction in stature is thus caused
by a combination of influences, including degree of
control and severity of asthma.
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Key messages
+ Social deprivation has an adverse effect on the height and weight
of children irrespective of any disease process
+ Neither asthma nor its treatments had any noticeable effect on the
height and weight of most of the children in this primary care
study
+ Children who received high doses of inhaled corticosteroids and
used hospital services for asthma were shorter and lighter than
their contemporaries after social deprivation was allowed for
+ Children receiving high doses of inhaled corticosteroids had lower
than normal growth rates
One hundred years ago
Special correspondence: Berlin
The Berlin vegetarians have a fine new feather in their caps. In a
walking match of 15 German miles, about 70 English miles, all
the 6 vegetarians who started passed the goal in perfect
condition, showing no trace of excessive fatigue, whilst of 11
non›vegetarians only one was able to hold out to the end, and he
arrived long after the others and very weary. The vegetarian victor
did the distance—comfortably from his account—in fourteen
hours and a quarter. He was sent for next day by the medical
department of the Prussian War Ministry, and interrogated as to
his training, diet, etc. (BMJ 1898;ii:116)
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